surmount 5 tirzepatide SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Zepbound will dominate obesity market

Amado understands that some patients may be more comfortable with a pill, while others may prefer an injection

The reduction in inflammation may be due in part to weight loss

Primary goals: Tissue repair, injury recovery, inflammation reduction, lean muscle support, sleep quality, energy

Journal of Thoracic and Cardiovascular Surgery 169: e18, 2025

The oak wood intervention also resulted in significant improvement in the liver enzymes AST and ALT, and in the liver fibrosis index, compared to the standard management group

Design your growth-peptide protocol Talk to a provider about whether Tesamorelin, CJC-1295, or a combination fits your goals and how to run it safely